High prevalence of fecal carriage of extended-spectrum beta-lactamase producing Enterobacterales among patients with urinary tract infections in rural Tanzania

被引:0
|
作者
Macha, Magreth Erick [1 ,2 ,3 ]
Qi, Weihong [4 ]
Seiffert, Salome N. [5 ]
Bosch, Anja [2 ]
Kohler, Philipp [6 ]
Urassa, Honorathy Msami [7 ]
Haller, Sabine [6 ]
West, Erin [8 ]
Rohacek, Maja Weisser [9 ,10 ,11 ]
Babouee Flury, Baharak [2 ,6 ,8 ,12 ]
机构
[1] St Francis Univ, Coll Hlth & Allied Sci, Ifakara, Tanzania
[2] Kantonsspital St Gallen, Med Res Ctr, St Gallen, Switzerland
[3] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland
[4] Univ Zurich, ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland
[5] Ctr Lab Med, Div Human Microbiol, St Gallen, Switzerland
[6] Kantonsspital St Gallen, Div Infect Dis Infect Prevent & Travel Med, St Gallen, Switzerland
[7] St Francis Reg Referral Hosp, Ifakara, Tanzania
[8] Kantonsspital St Gallen, Clin Trials Unit, St Gallen, Switzerland
[9] Univ Hosp Basel, Div Infect Dis, Basel, Switzerland
[10] Swiss Trop & Publ Hlth Inst, Allschwil, Switzerland
[11] Ifakara Hlth Inst, Ifakara, Tanzania
[12] Univ Bern, Bern Univ Hosp, Inselspital, Dept Infect Dis, Bern, Switzerland
关键词
fecal carriage; extended-spectrum beta-lactamase; enterobacterales; urinary tract infections; rural Tanzania; ESBL-PRODUCING ENTEROBACTERIACEAE; COMMUNITY; HIV;
D O I
10.3389/fmicb.2024.1517182
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Introduction The global rise of extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) challenges resource-limited countries with insufficient laboratory infrastructure. This study investigates fecal carriage and risk factors for ESBL-PE and carbapenemase-producing organisms among patients with urinary tract infection (UTI) in rural Tanzania. Methods This cross-sectional study was conducted at St. Francis Regional Referral Hospital, Ifakara, Tanzania, from October 2021 to August 2023, involving 326 UTI patients. Demographic data and resistance risk factors were collected via structured questionnaires. Stool samples collected pre-antibiotic treatment were screened for ESBL-PE and carbapenemase locally. Positive samples underwent further analysis in Switzerland using MALDI-ToF, Vitek MS, and whole-genome sequencing. Multivariable analysis assessed predictors associated with ESBL-PE carriage for risk factors with p < 0.05. Results We enrolled 326 UTI patients (median age: 35.5 years, range: 25-52) and 189 (58.0%) were females. Fecal ESBL-PE colonization was detected in 70.9% of patients, predominantly E. coli (62.8%) and K. pneumoniae (33.0%). Whole-genome sequencing identified diverse phylogroups and sequence types, with CTX-M-15 being the most common ESBL gene. IncF plasmids were the primary carriers. Younger age (aOR: 0.98, 95% CI: 0.97-0.99; p = 0.0239) and inpatient status (aOR: 1.77, 95% CI: 1.08-2.91; p = 0.0036) were significant risk factors for ESBL-PE carriage. Conclusion The high prevalence of ESBL-PE fecal carriage in rural Tanzania highlights the need for improved infection control and further research into community transmission dynamics.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Impact of fecal carriage of extended-spectrum beta-lactamase producing Enterobacteriaceae on the outcomes of transrectal needle biopsies of the prostate
    Tukenmez Tigen, Elif
    Ergonul, Onder
    Altinkanat, Gulsen
    Ozgen, Mahir
    Erturk Sengel, Buket
    Odabasi, Zekaver
    Turkeri, Levent
    Mulazimoglu, Lutfiye
    Korten, Volkan
    MARMARA MEDICAL JOURNAL, 2013, 26 (03): : 127 - 129
  • [32] Urinary tract infections in older adults: associated factors for extended-spectrum beta-lactamase production
    Alkan, Sena
    Balkan, Ilker Inanc
    Surme, Serkan
    Bayramlar, Osman Faruk
    Kaya, Sibel Yildiz
    Karaali, Ridvan
    Mete, Bilgul
    Aygun, Gokhan
    Tabak, Fehmi
    Saltoglu, Nese
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [33] Efficacy of Noncarbapenem β-Lactams Compared to Carbapenems for Extended-Spectrum β-Lactamase-Producing Enterobacterales Urinary Tract Infections
    Anderson, Daniel T.
    Albrecht, Benjamin
    Jones, K. Ashley
    Jacob, Jesse T.
    Sexton, Mary Elizabeth
    Wiley, Zanthia
    Dube, William C.
    Lee, Benjamin
    Suchindran, Sujit
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (03):
  • [34] Fecal Microbiome Features Associated with Extended-Spectrum β-Lactamase-Producing Enterobacterales Carriage in Dairy Heifers
    Cohen, Adar
    Poupko, Liat
    Craddock, Hillary A.
    Motro, Yair
    Khalfin, Boris
    Zelinger, Amit
    Tirosh-Levy, Sharon
    Blum, Shlomo E.
    Steinman, Amir
    Moran-Gilad, Jacob
    ANIMALS, 2022, 12 (14):
  • [35] Extended spectrum beta-lactamase urinary tract infections during pregnancy
    Kelly, B.
    Beninati, M.
    Davidson, C.
    Clark, S. L.
    Eppes, C. S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (06) : 835 - 835
  • [36] High prevalence of fecal carriage of extended-spectrum β-lactamase/AmpC-producing Enterobacteriaceae in cats and dogs
    Hordijk, Joost
    Schoormans, Anky
    Kwakernaak, Mandy
    Duim, Birgitta
    Broens, Els
    Dierikx, Cindy
    Mevius, Dik
    Wagenaar, Jaap A.
    FRONTIERS IN MICROBIOLOGY, 2013, 4
  • [37] Intestinal carriage of extended-spectrum beta-lactamase–producing Enterobacteriaceae at admission in a Portuguese hospital
    Marta Aires-de-Sousa
    Elizeth Lopes
    Maria Luísa Gonçalves
    Ana Luísa Pereira
    Augusto Machado e Costa
    Hermínia de Lencastre
    Laurent Poirel
    European Journal of Clinical Microbiology & Infectious Diseases, 2020, 39 : 783 - 790
  • [38] Treatment duration of complicated urinary tract infections by extended-spectrum beta-lactamases producing enterobacterales
    Otero, Judith Alvarez
    Lamas Ferreiro, Jose Luis
    Rivo, Ana Sanjurjo
    Pineiro, Fernando Maroto
    Gonzalez, Lucia Gonzalez
    de Salamanca Holzinger, Ignacio Enriquez
    Cavero, Jorge
    Conde, Irene Rodriguez
    Sonelra, Maria Fernandez
    De la Fuente Aguado, Javier
    PLOS ONE, 2020, 15 (10):
  • [39] Prevalence and risk factors for extended spectrum beta-lactamase producing Escherichia coli in patients with urinary tract infection
    Matsumoto, Minori
    Tanaka, Kazushi
    Takechi, Yoshizumi
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S262 - S262
  • [40] Prevalence and risk factors for extended spectrum beta-lactamase producing Escherichia coli in patients with urinary tract infection
    Matsumoto, M.
    Fukunaga, H.
    Tanaka, K.
    Takechi, Y.
    Yamada, Y.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 140 - 140